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Methicillin-resistant Staphylococcus aureus (MRSA) car-
riage may be more frequent in individuals originating from
countries known to have a high MRSA prevalence. In the
study presented here, the prevalence of MRSA carriers
among healthy pregnant women from former Yugoslavia
living in Switzerland was evaluated by surveillance of
screening cultures. Among 152 women screened, no
MRSA carrier was detected (95% confidence interval for
carriage prevalence, 0–1.9%). Currently, specific infection
control measures such as routine screening for MRSA at
hospital admission do not seem necessary in this patient
population.
In recent years, methicillin-resistant Staphylococcus
aureus (MRSA) strains have been recognized in outpatients
and are now known as community-acquired MRSA
(CA-MRSA). These strains differ from hospital-acquired
(HA-MRSA) strains. CA-MRSA strains are being reported
from an increasing number of countries, including those
with a low prevalence of HA-MRSA. At the University
Hospital Bern, the prevalence of HA-MRSA is below 5%,
and routine screening for MRSA carriage is restricted to
inpatients and patients referred from a foreign hospital.
However, in recent months several cases of vaginal MRSA
carriage have been detected by chance in women giving
birth (unpublished observation). It is noteworthy that a high
percentage of these women were originally from former
Yugoslavia. In countries such as Croatia, the prevalence of
HA-MRSA has been reported to be 22% [1], but no data
have yet been published on the occurrence of CA-MRSA in
that country.
Between 12 January 2004 and 5 January 2005 we
performed a screening study to evaluate MRSA carriage in
pregnant women from former Yugoslavia at the obstetrical
outpatient clinic of the University Hospital Bern, a tertiary
care center with more than 1,000 births per year. The study
was performed in accordance with the guidelines of the
local ethical committee. During the study period, each
woman was screened once for MRSA carriage at an
antenatal check.
Screening was performed by the treating physician in
accordance with written in-house guidelines. Using twisted
wire rayon-tipped applicators (Copan Venturi Transystem;
Copan, Brescia, Italy) premoistened with physiological
saline, nasal swabs were taken from both nares (same
applicator) and vaginal swabs were taken from the introitus
vaginae, including the perineal region. Microbiological
screening and identification of MRSAwere performed using
the mannitol/oxacillin biplate test, selective culture for gram-
positive organisms, and the coagulase tube test for exclusion
of coagulase-negative Staphylococcus spp; antimicrobial
resistance testing was performed using Müller–Hinton agar.
Patients’ data were collected from clinical charts and hospital
statistics using a standardized questionnaire. The 95%
confidence interval for MRSA prevalence was calculated
based on a binomial distribution.
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A total of 152 women were screened for MRSA carriage,
and no MRSA carrier was detected (confidence interval for
carriage prevalence, 0–1.9%). Women presented either on
their own initiative (64%) or following referral from
practitioners (28%) or other hospitals (9%). The mean age
was 25.1 years (±4.93, range 18–40 years). The women
originated mainly from Serbia, Montenegro and Kosovo
(51%) and Macedonia (32%). About one-third (38%) had
immigrated to Switzerland since 2001 and 14 (9%) had
immigrated during the 12-month period preceding MRSA
screening. About half of the women were housewives (54%)
and only a few worked in a healthcare setting (5%). There
were 78 (51%) nulliparae women, 42 were primiparae (28%)
and 31 (20%) had given birth two or more times previously.
MRSA screening was performed at a mean of 23 3/7 (range
7 0/7–40 4/7) weeks of pregnancy. At least 15 (10%) women
visited their home country during their pregnancy and eight
(5%) reported having a medical consultation while in their
home country. During the 12 months before MRSA
screening, 12 (8%) women had had surgery; in eight of
them this consisted of curettage for incomplete abortion.
Antibiotic therapy was prescribed to 26 (17%) women
during pregnancy. Only four (3%) were treated with a
vaginally applied disinfectant (chlorhexidine).
Our results show the prevalence of MRSA carriage
among women of childbearing age from former Yugoslavia
was very low in this region of Switzerland. Screening of the
genital tract for MRSA colonization has been rarely
performed until now. Dancer and Noble [2] reported data
on 500 pregnant women who were screened for Staphylo-
coccus aureus using nasal, axillary and perineal swabs, and
33% were found to be carriers. However, that study did not
indicate whether the three MRSA isolates detected were
collected from the perineum. With respect to MRSA
infections, a recently published case series showed that 12
of 57 pregnant women had an infection of the vulva or groin
[3].
Few studies have examined the prevalence of MRSA in
the Swiss community [4–6]; however, two surveys found
varying patterns of geographical distribution of MRSA
among drug users [4, 5]. A recent study performed in
Geneva in western Switzerland found CA-MRSA in
roughly 0.1% of 14,000 patients screened at hospital
admission [6]. This low prevalence of CA-MRSA is in
accordance with several community-based screenings in
other European states [7, 8]. However, recent investigations
point to an increase of CA-MRSA in Europe [9].
MRSA carriage in otherwise healthy individuals without
a relevant history of hospital contact has been shown in the
case of Kosovan refugees in Denmark [10], a finding which
probably reflects the earlier mentioned increase in MRSA
prevalence in former Yugoslavia [1]. Yet, a familial link to
a region with an impaired healthcare system does not seem
to predict carriage of nosocomial pathogens, as our results
indicate. Therefore, specific infection control measures
such as routine screening for MRSA at hospital admission
do not seem to be necessary in this patient population in
Switzerland.
Acknowledgements We would like to thank L. Beul, S. Burri, S.
Droz, R. Kuhn and T. Löhri for technical assistance. The study
complied with current Swiss law.
References
1. Tambic Andrasevic A, Tambic T, Kalenic S, Jankovic V (2002)
Surveillance for antimicrobial resistance in Croatia. Emerg Infect
Dis 8:14–18
2. Dancer SJ, Noble WC (1991) Nasal, axillary, and perineal carriage
of Staphylococcus aureus among women: identification of strains
producing epidermolytic toxin. Pathol 44:681–684
3. Laibl VR, Sheffield JS, Roberts S, McIntire DD, Trevino S,
Wendel GD (2005) Clinical presentation of community-acquired
methicillin-resistant Staphylococcus aureus in pregnancy. Obstet
Gynecol 106:461–465
4. Fleisch F, Zbinden R, Vanoli C, Ruef C (2001) Epidemic spread
of a single clone of methicillin-resistant Staphylococcus aureus
among injection drug users in Zurich, Switzerland. Clin Infect Dis
32:581–586
5. Bassetti S, Wolfisberg I, Jaussi B, Frei R, Kuntze MF, Battegay
M, Widmer AF (2004) Carriage of Staphylococcus aureus among
injection drug users: lower prevalence in an injection heroin
maintenance program than in an oral methadone program. Infect
Control Hosp Epidemiol 25:133–137
6. Harbarth S, François P, Schrenzel J, Fankhauser-Rodriguez C,
Hugonnet S, Koessler T, Huyghe A, Pittet D (2005) Community-
associated methicillin-resistant Staphylococcus aureus, Switzerland.
Emerg Inf Dis 11:962–965
7. Sa-Leao R, Sanches IS, Couto I, Alves CR, de Lencastre H (2001)
Low prevalence of methicillin-resistant strains among Staphylo-
coccus aureus colonizing young and healthy members of the
community in Portugal. Microb Drug Resist 7:237–245
8. Abudu L, Blair I, Fraise A, Cheng KK (2001) Methicillin-resistant
Staphylococcus aureus (MRSA): a community-based prevalence
survey. Epidemiol Infect 126:351–356
9. Wannet WJ, Spalburg E, Heck ME, Pluister GN, Tiemersma E,
Willems RJ, Huijsdens XW, de Neeling AJ, Etienne J (2005)
Emergence of virulent methicillin-resistant Staphylococcus aureus
strains carrying the Panton–Valentine leucocidin genes in the
Netherlands. J Clin Microbiol 43:3341–3345
10. Hansen B, Pedersen LN, Arpi M, Obel N (2000) Incidence of
methicillin-resistant Staphylococcus aureus among Kosovar–Al-
banian refugees at the refugee-center in Randers. Ugeskr Laeger
162:6241–6243
536 Eur J Clin Microbiol Infect Dis (2006) 25:535–536
